Sunshine Biopharma, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$160.00 | -$160.00 | -$160.00 |
| Q2 2024 | 1 | -$0.60 | -$0.60 | -$0.60 |
| Q3 2024 | 1 | -$535.00 | -$535.00 | -$535.00 |
| Q4 2024 | 1 | $256.00 | $256.00 | $256.00 |
Sunshine Biopharma, Inc. Earnings Date And Information
Sunshine Biopharma, Inc. last posted its earnings results on Tuesday, November 5th, 2024. The company reported $-0.94 earnings per share for the quarter, missing analysts' consensus estimates of $9 by $9.94. The company had revenue of 8.44 M for the quarter and had revenue of 24.09 M for the year. Sunshine Biopharma, Inc. has generated $-370 earnings per share over the last year ($-370.41 diluted earnings per share) and currently has a price-to-earnings ratio of -0.69. Sunshine Biopharma, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 26th, 2025 based on prior year's report dates.
Sunshine Biopharma, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/05/2024 | Q3 2024 | $9.00 | -$0.94 | -9.94 | $11.80 M | $8.44 M |
| 08/20/2024 | Q2 2024 | -$9.94 | $9.00 M | $9.30 M | ||
| 05/20/2024 | Q1 2024 | -$1.04 | -$40.04 | -39 | $7.54 M | |
| 03/28/2024 | Q4 2023 | -$3.00 | -$104.69 | -101.69 | $7.68 M | |
| 11/13/2023 | Q3 2023 | -$0.06 | -$50.72 | -50.66 | $6.00 M | $5.96 M |
| 08/10/2023 | Q2 2023 | -$0.71 | $5.00 M | $5.56 M | ||
| 05/10/2023 | Q1 2023 | -$154.51 | $4.89 M | |||
| 12/31/2022 | Q4 2022 | -$1.05 | $3.94 M | |||
| 11/07/2022 | Q3 2022 | -$7.71 | $132,808 | |||
| 08/03/2022 | Q2 2022 | -$2.41 | $150,307 | |||
| 05/06/2022 | Q1 2022 | -$7.82 | $122,645 | |||
| 03/21/2022 | Q4 2021 | $0.65 | $85,118 | |||
| 11/09/2021 | Q3 2021 | -$26.48 | $50,376 | |||
| 08/09/2021 | Q2 2021 | -$20.06 | $52,874 | |||
| 05/11/2021 | Q1 2021 | -$46.99 | $40,058 | |||
| 03/30/2021 | Q4 2020 | -$6.43 | $28,013 | |||
| 11/10/2020 | Q3 2020 | -$4.15 | $17,150 | |||
| 08/19/2020 | Q2 2020 | -$3.48 | $15,145 | |||
| 05/18/2020 | Q1 2020 | -$0.50 | $11,102 | |||
| 04/30/2020 | Q4 2019 | -$2.11 | $10,556 |
Sunshine Biopharma, Inc. Earnings: Frequently Asked Questions
-
When is Sunshine Biopharma, Inc.'s earnings date?
Sunshine Biopharma, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 26th, 2025 based off last year's report dates.
-
How can I listen to Sunshine Biopharma, Inc.'s earnings conference call?
The conference call for Sunshine Biopharma, Inc.'s latest earnings report can be listened to online.
-
How can I read Sunshine Biopharma, Inc.'s conference call transcript?
The conference call transcript for Sunshine Biopharma, Inc.'s latest earnings report can be read online.
-
How much revenue does Sunshine Biopharma, Inc. generate each year?
Sunshine Biopharma, Inc. (:SBFM) has a recorded annual revenue of $24.09 M.
-
How much profit does Sunshine Biopharma, Inc. generate each year?
Sunshine Biopharma, Inc. (:SBFM) has a recorded net income of $24.09 M. Sunshine Biopharma, Inc. has generated $-370.41 earnings per share over the last four quarters.
-
What is Sunshine Biopharma, Inc.'s price-to-earnings ratio?
Sunshine Biopharma, Inc. (:SBFM) has a price-to-earnings ratio of -0.69 and price/earnings-to-growth ratio is -0.03.
